GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » 5-Year EBITDA Growth Rate

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2007)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition 5-Year EBITDA Growth Rate?

Oracle Healthcare Acquisition's EBITDA per Share for the three months ended in Dec. 2007 was $0.25.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate falls into.


Oracle Healthcare Acquisition 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Oracle Healthcare Acquisition  (OTCPK:OHAQ) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Oracle Healthcare Acquisition 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » 5-Year EBITDA Growth Rate
Comparable Companies
BOM:531043 MIHI LMNK TONJ HPHW WAR:SWD BOM:523489 SPIN USNU WAR:DLK BOM:534422 TSXV:AHI BOM:540812 BNKL BOM:530897 XSAT:PLUN LSE:VENN XAMS:ESP GRST ORSE:LJM1R
Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines